362 related articles for article (PubMed ID: 11529208)
1. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
2. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
3. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.
Verne JE; Aubrey R; Love SB; Talbot IC; Northover JM
BMJ; 1998 Jul; 317(7152):182-5. PubMed ID: 9665902
[TBL] [Abstract][Full Text] [Related]
4. Adenoma characteristics in the English Bowel Cancer Screening Programme.
Majumdar D; Bevan R; Essam M; Nickerson C; Hungin P; Bramble M; Rutter MD
Colorectal Dis; 2024 Apr; 26(4):643-649. PubMed ID: 38433121
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Sessile Serrated Lesions in Individuals With Positive Fecal Immunochemical Test Undergoing Colonoscopy: Results From a Large Nationwide Veterans Affairs Database.
Wilson N; Bilal M; Westanmo A; Gravely A; Shaukat A
Gastroenterology; 2024 Jun; 166(6):1170-1173.e2. PubMed ID: 38431206
[No Abstract] [Full Text] [Related]
6. Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin.
Iles-Shih L; Collins JF; Holub JL; Lieberman DA
Am J Gastroenterol; 2010 Sep; 105(9):2030-4; quiz 1962, 2035. PubMed ID: 20683445
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening: the northern trust experience.
Neely D; Campbell W; Davey P; Rodgers C; McCrory D
Ulster Med J; 2013 Sep; 82(3):160-3. PubMed ID: 24505151
[TBL] [Abstract][Full Text] [Related]
8. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
[TBL] [Abstract][Full Text] [Related]
9. A survey of individual preference for colorectal cancer screening technique.
Nelson RL; Schwartz A
BMC Cancer; 2004 Nov; 4():76. PubMed ID: 15533242
[TBL] [Abstract][Full Text] [Related]
10. Results of faecal immunochemical test for colorectal cancer screening, in average risk population, in a cohort of 1389 subjects.
Miuţescu B; Sporea I; Popescu A; Bota S; Iovănescu D; Burlea A; Mos L; Miuţescu E
Clujul Med; 2013; 86(2):102-6. PubMed ID: 26527927
[TBL] [Abstract][Full Text] [Related]
11. Delivery of cancer screening: how important is the preventive health examination?
Fenton JJ; Cai Y; Weiss NS; Elmore JG; Pardee RE; Reid RJ; Baldwin LM
Arch Intern Med; 2007 Mar; 167(6):580-5. PubMed ID: 17389289
[TBL] [Abstract][Full Text] [Related]
12. A prediction model for colon cancer surveillance data.
Good NM; Suresh K; Young GP; Lockett TJ; Macrae FA; Taylor JM
Stat Med; 2015 Aug; 34(18):2662-75. PubMed ID: 25851283
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for colon cancer screening.
Pignone M; Bucholtz D; Harris R
J Gen Intern Med; 1999 Jul; 14(7):432-7. PubMed ID: 10417601
[TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
Gabriele R; Campagnol M; Iannone I; Sapienza P; Borrelli V; Sterpetti AV
Br J Surg; 2024 May; 111(5):. PubMed ID: 38788698
[No Abstract] [Full Text] [Related]
15. 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality.
Juul FE; Cross AJ; Pinsky P; Senore C; Løberg M
Ann Intern Med; 2023 Jun; 176(6):eL230025. PubMed ID: 37335997
[No Abstract] [Full Text] [Related]
16. Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy.
McGregor SE; Ritvo P; Tinmouth J; Kornblum A; Myers R; Hilsden RJ; Paszat LF; Rabeneck L
Can J Gastroenterol; 2011 May; 25(5):248-52. PubMed ID: 21647457
[TBL] [Abstract][Full Text] [Related]
17. Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
Ionescu EM; Nicolaie T; Ionescu MA; Becheanu G; Andrei F; Diculescu M; Ciocirlan M
J Med Life; 2015; 8(3):398-403. PubMed ID: 26351547
[TBL] [Abstract][Full Text] [Related]
18. Simulated performance of flexible sigmoidoscopy-based screening for advanced neoplasia detection in a Greek population.
Papastergiou V; Mathou N; Giannakopoulos A; Evgenidi A; Schoretsanitis E; Papaparaskeva K; Apessou D; Paraskeva KD
Ann Gastroenterol; 2020; 33(2):187-194. PubMed ID: 32127740
[TBL] [Abstract][Full Text] [Related]
19. Should we perform sigmoidoscopy for colorectal cancer screening in people under 45 years?
Leong W; Guo JQ; Ning C; Luo FF; Jiao R; Yang DY
World J Gastrointest Oncol; 2024 Apr; 16(4):1248-1255. PubMed ID: 38660667
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications.
Szilagyi A; Xue X
Clin Exp Gastroenterol; 2017; 10():285-292. PubMed ID: 29184430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
